Fuller-Fleming Lectures

The Sarah W. Fuller, CW’71, and Samuel Fleming Lecture in Life Sciences & Management was originally established as the Decision Resources Distinguished Lecture, named for the firm Decision Resources (now Clarivate) under the guidance of its co-founders, Samuel C. Fleming, CEO 1989 – 2003, and Sarah W. Fuller, C’71, President 1989 – 2012. As a global leader in providing strategic information to the biopharmaceutical, medical device and health-insurance industries, the firm they founded epitomizes the philosophy behind the LSM program. The University is therefore honored to have the late Sarah Fuller and the late Sam Fleming as the sponsors of this annual lecture series, which brings leaders in the fields of science and business to Penn’s campus.

As founders of this lecture series, Sarah Fuller and Sam Fleming have inspired and will continue to inspire the Vagelos Program in Life Sciences and Management. If it were not for their vision we in Penn and the local community at large would not have what amounts to one of the most memorable public events offered by the program. Sarah and Sam will live on in the hearts and minds of those they have influenced and continue to influence through their legacy.

2023 Fuller-Fleming Lecture:

Ala Stanford, MD

Founder, Black Doctors Consortium and Center for Health Equity
Former U.S. HHS Regional Director, Mid-Atlantic Region
Faith, Focus and Fortitude: A Surgeon's Health Justice Journey

Wednesday, November 1st 6:00PM - 7:30PM

Bodek Lounge, Houston Hall, 3417 Spruce Street, Philadelphia

Reception to Follow


Past Fuller-Fleming Lectures:

2022: Dr. Mark V. Pauly

Professor Emeritus of Healthcare Management
The Wharton School, University of Pennsylvania
Is the U.S. Healthcare System Really in Poor Health?


2019: Jack C. Chow, M.D., M.B.A., M.P.A.

Former U.S. Ambassador, and Distinguished Service Professor
Heinz College of Public Policy, Carnegie Mellon University
The Premise and Promise of Global Health Diplomacy


2018: Lynn M. Schuchter, M.D.

C. Willard Robinson Professor of Hematology-Oncology, Chief of Hematology/Oncology Division, Perelman School of Medicine
Melanoma Program Leader, Abramson Cancer Center of the University of Pennsylvania
More Than Skin Deep: Insights from Melanoma


2017: Ken Frazier, J.D.

Chairman of the Board and CEO, Merck & Co. Inc.
Inventing for Life: Balancing Biomedical Research with the Bottom Line


2016: David Fajgenbaum, M.D., M.B.A., M.Sc.

Co-Founder and Executive Directors of the Castleman Disease Collaborative Network (CDCN)
Research Assistant Professor of Medicine, Division of Translational Medicine & Human Genetics, Perelman School of Medicine, University of Pennsylvania
When Every Second Counts: Using Business Principles to Defeat Castleman Disease

2015: George Yancopoulos, M.D., Ph.D.

Founding Scientist, President, Regeneron Laboratories & Chief Scientific Officer, Regeneron
Building a Better Biotech: The Regeneron Story

2014: Jean Bennett, M.D., Ph.D.

F.M. Kirby Professor of Molecular Opthalmology, Perelman School of Medicine
Seeing is Believing: The Emergence of Rare Disease as a Stepping Stone to Drug Development

2013: Joaquin Duato

Worldwide Chairman, Pharmaceuticals, Johnson & Johnson
Future Forward: New Directions in Meeting Global Health Needs

2012: Paul Offit, M.D.

Chief, Division of Infectious Diseases, Children's Hospital of Pennsylvania, and Maurice R. Hilleman Professor of Vaccinology, University of Pennsylvana School of Medicine
Communicating Science to the Public

2011: Daniel Janzen, Ph.D.

DiMaura Professor of Conservation Biology, University of Pennsylvania, and
Founder, Área de Conservación Guanacaste
Conservation of a Large Tropical Wildland through its Biodiversity Development

2010: Margaret G. McGlynn

Former President of Global Vaccines and Anti-Infectives, Merck & Co., Inc.
Leveraging Science and Business Skills to Impact Global Health

2009: Barry R. Bloom, Ph.D.

Distinguished University Service Professor and Jack and Joan Jacobson Professor of Public Health, Harvard University School of Public Health
The Unfinished Agenda of Infectious Diseases

2008: Philip Needleman, Ph.D.

Former Professor and Chairman, Department of Pharmacology, Washington University Medical School, and Former Chief Scientist and Head of R&D, Monstanto/Searle/Pharmacia
Lessons Learned from Turning a Research Idea into a Drug Used by Millions

2007: Art Caplan, Ph.D.

Emanuel and Robert Hart Professor of Bioethics; Chair, Department of Medical Ethics,
and Director, Center for Bioethics, University of Pennsylvania
A Long and Winding Road: The Evolution of Bioethics from Bedside to Boardroom

2006: Steven A. Nichtberger, M.D.

President and CEO, Tengion, Inc.
Turning Scientific Advances into Transformational Products: Opportunities and Challenges for the Scientist-Business Leader